Intensified and Continuous Upstream (USP) Processing
Future-proof your manufacturing strategies, reduce costs and increase facility flexibility with intensified fed-batch and perfusion processes
Make the best decisions to increase productivity, reduce costs, improve facility flexibility, and future-proof manufacturing strategies by intensifying your upstream process.
Biopharmaceutical developers and manufacturers need efficient, productive upstream processes that deliver high-quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification, including intensified fed-batch and perfusion processes, offers many options to future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
With a full suite of solutions designed to support the increased demands of intensified upstream processes and technical support from teams with years of experience, we can support you in choosing the best strategies to realize the benefits of upstream process intensification without compromising clinical milestones or speed to market.
Intensified and Continuous Upstream (USP) Processing
Intensified and Continuous Upstream (USP) Processing
Today’s biopharmaceutical manufacturers are confronted with numerous challenges:
- Speed-to-market and cost-efficient production for competitive advantage
- Flexibility to increase throughput or target a smaller patient population
- Agility to process multiple products in a single facility
- High volumetric productivity with a smaller facility footprint
Upstream process intensification, as a cornerstone of this transformation, can deliver new gains in efficiency while sustaining or improving product quality. Innovative approaches are needed to address these challenges and future-proof manufacturing strategies for the facility of the future. We have developed several upstream intensification strategies for seed train and production and harvest processes, including high cell density cryopreservation and perfusion solutions. Whether you’re developing an intensified fed-batch or perfusion process, our integrated solutions enable you to increase volumetric productivity which can translate into higher throughput, improved facility utilization and flexibility, compressed timelines, and reduced manufacturing and capital costs. With technical support from a global team with extensive application and regulatory expertise we empower you to take the right decisions faster.
Connect with our experts to evaluate how we can help you make the right decisions for upstream intensification.
Related Categories
Perfusion operations deliver high-density cell cultures that alleviate the burden of processing large production bioreactor...
Mobius® products and solutions can help you meet your evolving cell culture needs...
With our comprehensive portfolio, you can choose from tried-and-true formulations...
Streamline biopharma manufacturing with Mobius® 2D and 3D single-use assemblies.
A cell line that maintains favorable growth and productivity is vital for mab manufacturing.
Related Resources
- Mobius® iFlex Bioreactors for Fed-Batch and Perfusion Upstream Processes
The Mobius® iFlex Bioreactor takes modular flexibility, scalability, ergonomics...
- Mobius® Breez Microbioreactor for Perfusion Process Development
The pressure to reduce manufacturing costs is driving the need to improve process efficiency and flexibility...
- Cell Retention Technology and Specialized Cell Culture Media for Intensified Upstream Processing
This study demonstrates the use of a Cellicon® filter and controller in an N-1 perfusion process with Cellvento® 4CHO-X expansion medium as compared to a control seed train using shake flasks.
- Reproducible Scaling of a Cell Retention Filter Using the Cellicon® Cell Retention Solution
This page describes the design attributes of the Cellicon® Filter Assembly and how they simplify process scale-up.
- Operational and Financial Advantages of Cellicon® Cell Retention Solution in an N-1 Perfusion Process
The following study compares an N-1 perfusion process at the 2,000 L scale using our Cellicon® Cell Retention Solution versus a commercially available cell retention device.
- Seed Train Intensification Using High Cell Density Cryopreservation
This article explains the benefits of high cell density cryopreservation (HCDC) and how to implement it.
- Impact of DMSO And Freezing Technique in Developing a High Cell Density Cryopreservation Process for Upstream Bioprocessing
Here, we evaluated how dimethyl sulfoxide and freezing techniques impact viable cell density and titer production in an HCDC intensified seed train.
- Preparing CHO Cells for Higher Productivity by Optimizing a Perfused Seed Train
This application note describes the benefits and performance of Cellvento® 4CHO-X Expansion Medium designed for multiple cell expansion steps from vial thaw to N-1 stages to generate higher biomass for inoculating fed-batch production bioreactors.
- Flyer: Mobius® Breez Microbioreactor
A 2 mL Automated Perfusion Cell Culture Platform: Do more with less and accelerate your path to process intensification.
Related Webinars
This webinar describes a new microbioreactor system that fulfills throughput-performance gap, providing single-use, perfusion bioreactors with 2mL working volume.
Explore the advantage of adopting a perfusion-specific CLD process to create more productive clones, providing an integrated solution for intensified processing.
We discuss the use of a high cell density cryopreservation (HCDC) method that utilizes bag assemblies specifically designed for freezing cells at higher densities and larger volumes.
Intensified upstream bioprocesses are being developed to increase productivity while reducing footprint, costs, and timelines for manufacturing.
Learn how perfused seed train options could deliver lower cost of goods, increase product throughput, or a combination of both.
Media composition plays a critical role for biopharmaceutical production as well as seed train expansion.
Upstream process intensification can bring significant benefits in terms of smaller facilities, manufacturing flexibility, and reduction in footprint.
Related Videos
BioContinuum™ Platform: Your enabler of the biomanufacturing facility of the future!
Per continuare a leggere, autenticati o crea un account.
Non hai un Account?